Radiofrequency ablation: A safe and effective treatment in nonoperative patients with early-stage lung cancer

Cancer Journal

Volumn 17, Issue 1, 2011, Pages 33-37

  Healey, Terrance T ^a   Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

interventional oncology; lung cancer; lung tumors; Radiofrequency ablation (RFA); thermal ablation

Indexed keywords

FLUORODEOXYGLUCOSE; GABAPENTIN; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT;

AIR EMBOLISM; BRONCHOPLEURAL FISTULA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EARLY CANCER; FEVER; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG HEMORRHAGE; LUNG NON SMALL CELL CANCER; NEUROPATHIC PAIN; PATIENT SAFETY; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; REVIEW; STROKE; SURGICAL TECHNIQUE; SURGICAL TECHNOLOGY; THORAX PAIN; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 79551521476     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e318209176f     Document Type: Review

References (43)

1. American Cancer Society. Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615-622; discussion 622-623.
3. Qaio X, Tullgren O, Lax I, et al. The role of radiotherapy in the treatment of stage 1 non-small cell lung cancer. Lung Cancer. 2003;41:1-11.
4. Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage 1 non-small-cell lung cancer. J Thorac Cardiovasc Surg. 2009;137:160-166.
5. Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage 1 non-small cell lung cancer in high risk patients. J Thorac Cardiovasc Surg. 2007;134:857-864.
6. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268-275.
7. Grieco CA, Simon CJ, Mayo-Smith WW, et al. Percutaneous imageguided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17:1117-1124.
8. Yamagami T, Kato T, Hirota T, et al. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms. Diagn Interv Radiol. 2007;13:199-203.
9. Nour-Eldin NE, Naguib NN, Saeed AS, et al. Risk factors involved in the development of pneumothorax during radiofrequency ablation of lung neoplasms. AJR Am J Roentgenol. 2009;193: W43-W48.
10. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol. 2007;62:639-644.
11. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer [published online ahead of print May 26, 2010]. J Am Coll Surg. 2010;211:68-72.
12. Jin GY, Lee JM, Lee YC, et al. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor. Am J Roentgenol. 2004;182:990-992.
13. Pennathur A, Abbas G, Gooding WE, et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg. 2009;88:1601-1606; discussion 1607-1608.
14. Beland MD, Wasser EJ, Mayo-Smith WW, et al. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology. 2010;254:301-307.
15. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol. 2005;185:1299-1306.
16. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466-471.
17. Jin GY, Lee JM, Lee YC, et al. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol. 2004;183:1013-1020.
18. Sharma A, Digumarthy SR, Kalra MK, et al. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors. AJR Am J Roentgenol. 2010;194:1250-1256.
19. Hiraki T, Gobara H, Mimura H, et al. Does tumor type affect local control by radiofrequency ablation in the lungs? Eur J Radiol. 2009;74:136-141.
20. Marasso A, Bemardi V, Gai R, et al. Radiofrequency resection of bronchial tumors in combination with cryotherapy: evaluation of a new technique. Thorax. 1998;53:106-109.
21. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621-628.
22. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumors: results in the mid-term. Eur J Cardiothorac Surg. 2006;30:177-183.
23. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancerVa preliminary report of 33 patients. AJR Am J Roentgenol. 2004;183:1003-1011.
24. Chua TC, Sarkar A, Saxena A, et al. Long-term outcome of imageguided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol. 2010;21:2017-2022.
25. Chua TC, Thornbury K, Saxena A, et al. Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer. 2010;116:2106-2114.
26. Das M, Abdelmaksoud MH, Loo BW Jr, et al. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time? Curr Treat Options Oncol. 2010;11:24-35.
27. Detterbeck FC. Radiofrequency ablation (RFA) of pulmonary metastases: technical success vs. actual benefit. Ann Surg Oncol. 2010;17:1214; author reply, 1215.
28. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57-59.
29. Gillams A. Tumour ablation: current role in the kidney, lung and bone. Cancer Imaging. 2009;9 spec no A:S68YS70.
30. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report [published online ahead of print November 26, 2003]. Radiology. 2004;230:125-134.
31. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol. 2004;183:361-368.
32. Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomographyguided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J. 2006;27:556-563.
33. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large singlecenter experience. Cancer. 2007;109:1397-1405.
34. Shu Yan Huo A, Lawson Morris D, King J, et al. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma [published online ahead of print August 13, 2009]. Ann Surg Oncol. 2009;16:3169-3175.
35. Thanos L, Mylona S, Ptohis N, et al. Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients. Diagn Interv Radiol. 2009;15:290-296.
36. Van Sonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experiencetechnical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol. 2005;184:381-390.
37. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology. 2004;231:850-857.
38. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small-cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129:639-644.
39. Hiraki T, Gobara H, Iishi T, et al. Percutaneous radiofrequency ablation for clinical stage 1 non-small-cell lung cancer: results in 20 non-surgical candidates. J Thorac Cardiovasc Surg. 2007;134:1306-1312.
40. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:738-745.
41. Brace CL, Hinshaw JL, Laeseke PF, et al. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009;251:705-711.
42. Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients [published online ahead of print May 27, 2008]. Radiology. 2008;247:871-879.
43. Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue-is microwave not just for popcorn anymore? Radiology. 2009;251:617-618.